Eurofins BioPharma Product Testing Switzerland

Our Swiss BioPharma team is proud to contribute to these strong accomplishments across continents. 🥼 🌍 As it is always encouraging to see how hard work pays off, we want to use the opportunity to thank our employees and partners for their commitment to our diversity and sustainability goals, and for their important contribution to our mutual success. 👏🏻 ✨ #diversity #sustainability #teamwork

𝗪𝗮𝗿𝗺 𝗛𝗼𝗹𝗶𝗱𝗮𝘆 𝗪𝗶𝘀𝗵𝗲𝘀 𝗳𝗿𝗼𝗺 𝗘𝘂𝗿𝗼𝗳𝗶𝗻𝘀 𝗕𝗶𝗼𝗣𝗵𝗮𝗿𝗺𝗮 𝗣𝗿𝗼𝗱𝘂𝗰𝘁 𝗧𝗲𝘀𝘁𝗶𝗻𝗴 𝗦𝘄𝗶𝘁𝘇𝗲𝗿𝗹𝗮𝗻𝗱 🎄✨ This season is a time to pause, celebrate, and recharge for the 𝗲𝘅𝗰𝗶𝘁𝗶𝗻𝗴 𝗼𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝗶𝗲𝘀 that lie ahead. Whether you’re wrapping up projects or taking a 𝘄𝗲𝗹𝗹-𝗱𝗲𝘀𝗲𝗿𝘃𝗲𝗱 𝗯𝗿𝗲𝗮𝗸, we hope this holiday season brings you moments of joy, relaxation, and time with loved ones. From our team to yours, happy holidays and best wishes for a successful and prosperous 2025! We look forward to 𝗰𝗼𝗻𝘁𝗶𝗻𝘂𝗶𝗻𝗴 𝗼𝘂𝗿 𝗰𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻 in the New Year. 🌐 https://lnkd.in/ec-cYE-r 📩 BioPharma.Switzerland@bpt.eurofinseu.com  #HappyHolidays #SeasonGreetings #Biopharma #Partnership #ThankYou 

𝗥𝗲𝗳𝗹𝗲𝗰𝘁𝗶𝗻𝗴 𝗼𝗻 𝟮𝟬𝟮𝟰: 𝗔 𝗬𝗲𝗮𝗿 𝗼𝗳 𝗣𝗮𝗿𝘁𝗻𝗲𝗿𝘀𝗵𝗶𝗽 𝗮𝗻𝗱 𝗣𝗿𝗼𝗴𝗿𝗲𝘀𝘀 As we approach the end of 2024, we want to express our gratitude to our biopharmaceutical clients in Switzerland. Your trust and collaboration have been the foundation of an incredible year filled with shared milestones and achievements.  𝗞𝗲𝘆 𝗮𝗰𝗰𝗼𝗺𝗽𝗹𝗶𝘀𝗵𝗺𝗲𝗻𝘁𝘀 𝗼𝗳 𝟮𝟬𝟮𝟰: • Integration of physical/chemical testing portfolio of Eurofins PHAST Development in Konstanz into Swiss operations  • Facility expansion in Schönenwerd by an additional 220 m2  • Expansion of our One-Stop-Shop service portfolio for Swiss clients • Integration of in-house logistics for sample pick-up services, for full flexibility • Introduction of our weekend service to accommodate our client's testing needs   • Launch of our Eurofins BPT Switzerland website, providing a comprehensive service overview  • Qualification of our new Recombinant Factor C (rFC) technology, a precise and animal-free alternative to traditional LAL testing for Endotoxins • Additional incubators and refrigerators to further increase our already high capacity for significant project peaks • Night refrigerators to maintain cold storage conditions for samples arriving at night And many more... These milestones would not have been possible without your partnership and commitment. As we step into 2025, we are excited 𝘁𝗼 𝗯𝘂𝗶𝗹𝗱 𝗼𝗻 𝘁𝗵𝗶𝘀 𝗺𝗼𝗺𝗲𝗻𝘁𝘂𝗺, explore new business opportunities, and address upcoming challenges together. With our shared vision for advancing the biopharmaceutical industry, we are confident that the coming year holds even greater success. 𝗧𝗵𝗮𝗻𝗸 𝘆𝗼𝘂 𝗳𝗼𝗿 𝗯𝗲𝗶𝗻𝗴 𝗽𝗮𝗿𝘁 𝗼𝗳 𝗼𝘂𝗿 𝗷𝗼𝘂𝗿𝗻𝗲𝘆! 🌐 https://lnkd.in/ec-cYE-r 📩 BioPharma.Switzerland@bpt.eurofinseu.com #ThankYou #BioPharma #Innovation #Partnership #2024Milestones #2025Opportunities 

𝗗𝗶𝘀𝘀𝗼𝗹𝘂𝘁𝗶𝗼𝗻 𝗧𝗲𝘀𝘁𝗶𝗻𝗴: 𝗘𝗻𝘀𝘂𝗿𝗶𝗻𝗴 𝗣𝗲𝗿𝗳𝗼𝗿𝗺𝗮𝗻𝗰𝗲 𝗧𝗵𝗿𝗼𝘂𝗴𝗵𝗼𝘂𝘁 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 Dissolution testing is a critical component of product development, as changes at various stages can impact dissolution performance and lead to unexpected outcomes. At 𝗘𝘂𝗿𝗼𝗳𝗶𝗻𝘀 𝗣𝗛𝗔𝗦𝗧 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗶𝗻 𝗞𝗼𝗻𝘀𝘁𝗮𝗻𝘇, our experts provide guidance through every phase of development, rigorously testing dissolution to ensure your product consistently meets regulatory and quality requirements. 𝗦𝘁𝗮𝗴𝗲 𝟭: 𝗣𝗿𝗲𝗳𝗼𝗿𝗺𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝗦𝘁𝘂𝗱𝗶𝗲𝘀  𝗚𝗼𝗮𝗹: Analyze the active pharmaceutical ingredient (API) to determine characteristics like particle size, polymorph, and wettability that influence formulation and dissolution. 𝗦𝘁𝗮𝗴𝗲 𝟮: 𝗜𝗻𝗶𝘁𝗶𝗮𝗹 𝗙𝗼𝗿𝗺𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁  𝗚𝗼𝗮𝗹: Choose a dosage form strategy and design a preliminary formulation. Focus Areas: • Evaluate how excipients, process influences, and food intake impact dissolution and bioavailability 𝗦𝘁𝗮𝗴𝗲 𝟯: 𝗔𝗱𝘃𝗮𝗻𝗰𝗲𝗱 𝗙𝗼𝗿𝗺𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁  𝗚𝗼𝗮𝗹: Optimize the formulation for clinical studies and commercial viability. Key Activities:  • Prepare clinical batches: Develop batches suitable for early-phase clinical trials.  • Stability testing: Evaluate how the formulation maintains dissolution properties under storage conditions.   • Scale up: Transition from small-scale to larger-scale production while ensuring batch-to-batch consistency in dissolution performance. 𝗦𝘁𝗮𝗴𝗲 𝟰: 𝗣𝗿𝗶𝗺𝗮𝗿𝘆 𝗦𝘁𝗮𝗯𝗶𝗹𝗶𝘁𝘆 𝗦𝘁𝘂𝗱𝗶𝗲𝘀  𝗚𝗼𝗮𝗹: Monitor dissolution performance over time to confirm product stability. Main Objectives:  • Dissolution profiling: Test at defined intervals (e.g., 0, 3, 6, 12 months) under specified storage conditions to identify any alterations in dissolution behavior that could impact bioavailability or regulatory compliance.   By closely collaborating with you at every critical stage, our team ensures that your product consistently meets dissolution expectations, delivering optimal therapeutic results. 𝗩𝗶𝘀𝗶𝘁 𝗼𝘂𝗿 𝘄𝗲𝗯𝘀𝗶𝘁𝗲 and submit the details via inquiry 🌐 https://lnkd.in/e-xjzyHq 𝗢𝗿 𝗰𝗼𝗻𝘁𝗮𝗰𝘁 𝗼𝘂𝗿 𝘁𝗲𝗮𝗺 𝗱𝗶𝗿𝗲𝗰𝘁𝗹𝘆  📩 Pharma.Konstanz@bpt.eurofinseu.com   📩 BioPharma.Switzerland@bpt.eurofinseu.com #Dissolution #DissolutionTesting #ProductDevelopment #QualityControl #BioPharma #Pharma #Eurofins #EurofinsBPT 

𝗨𝗻𝗹𝗼𝗰𝗸 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝘄𝗶𝘁𝗵 𝗔𝗱𝘃𝗮𝗻𝗰𝗲𝗱 𝗠𝗲𝘁𝗵𝗼𝗱 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗮𝗻𝗱 𝗩𝗮𝗹𝗶𝗱𝗮𝘁𝗶𝗼𝗻 𝗠𝗲𝘁𝗵𝗼𝗱 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗮𝗻𝗱 𝗩𝗮𝗹𝗶𝗱𝗮𝘁𝗶𝗼𝗻 are essential steps in ensuring the success and compliance of biopharma projects. At Eurofins PHAST Development in Konstanz, we combine expertise, innovative technology, and a collaborative approach to help you streamline these critical processes with confidence. 𝗪𝗵𝘆 𝗣𝗮𝗿𝘁𝗻𝗲𝗿 𝘄𝗶𝘁𝗵 𝗨𝘀? 𝗣𝗿𝗼𝘃𝗲𝗻 𝗘𝘅𝗽𝗲𝗿𝘁𝗶𝘀𝗲:  Extensive experience in executing 100+ successful validation-, qualification-, verification-, and transfer protocols performed under full cGMP compliance 𝗧𝗮𝗶𝗹𝗼𝗿𝗲𝗱 𝗔𝗽𝗽𝗿𝗼𝗮𝗰𝗵𝗲𝘀:  Projects designed to maximize efficiency and research budget while ensuring suitability for your intended use 𝗖𝗼𝗺𝗽𝗿𝗲𝗵𝗲𝗻𝘀𝗶𝘃𝗲 𝗦𝗲𝗿𝘃𝗶𝗰𝗲𝘀:  Covering Dissolution, Particles, Reference Materials, Chromatography and Storage Stability 𝗖𝗹𝗼𝘀𝗲 𝗖𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻:  Regular updates and seamless method transfer with receiving labs to ensure project success 𝗕𝗲𝗻𝗲𝗳𝗶𝘁 𝗳𝗿𝗼𝗺 𝗼𝘂𝗿 𝗖𝗼𝗺𝗽𝗿𝗲𝗵𝗲𝗻𝘀𝗶𝘃𝗲 𝗢𝗳𝗳𝗲𝗿𝗶𝗻𝗴𝘀! 𝟭. 𝗠𝗲𝘁𝗵𝗼𝗱 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁:  Defining the project scope and evaluating precision, linearity, accuracy, and specificity to ensure the method is fully prepared for validation. 𝟮. 𝗠𝗲𝘁𝗵𝗼𝗱 𝗢𝗽𝘁𝗶𝗺𝗶𝘇𝗮𝘁𝗶𝗼𝗻:  Refining analytical methods to enhance chromatographic resolution, support formulation modifications, or align with current industry standards. These adjustments ensure methods are robust and ready for validation.    𝟯. 𝗙𝗲𝗮𝘀𝗶𝗯𝗶𝗹𝗶𝘁𝘆 𝗦𝘁𝘂𝗱𝗶𝗲𝘀:  Conducted to confirm method performance under practical conditions. This step re-evaluates key attributes, minimizing the risk of protocol acceptance criteria failures. 𝟰. 𝗠𝗲𝘁𝗵𝗼𝗱 𝗤𝘂𝗮𝗹𝗶𝗳𝗶𝗰𝗮𝘁𝗶𝗼𝗻:  Assessing methods supporting early-phase products to confirm suitability for their intended use. Qualification may be conducted with or without a formal protocol, depending on project needs. 𝟱. 𝗠𝗲𝘁𝗵𝗼𝗱 𝗩𝗮𝗹𝗶𝗱𝗮𝘁𝗶𝗼𝗻:  Comprehensive validation of methods supporting later-phase products to ensure compliance with Ph. Eur., USP general chapters, and ICH guidelines. 𝟲. 𝗠𝗲𝘁𝗵𝗼𝗱 𝗩𝗲𝗿𝗶𝗳𝗶𝗰𝗮𝘁𝗶𝗼𝗻:  Confirming compendial methods perform effectively with your API or product matrix, following a detailed protocol. Our experts are ready to support you in developing robust, reliable, and compliant methods that guide your product lifecycle from start to finish. 📩 Pharma.Konstanz@bpt.eurofinseu.com  📩 BioPharma.Switzerland@bpt.eurofinseu.com #MethodDevelopment #MethodValidation #GMP #Biopharma #AnalyticalServices #QualityControl 

𝗜𝗺𝗽𝘂𝗿𝗶𝘁𝘆 𝗧𝗲𝘀𝘁𝗶𝗻𝗴 𝗳𝗼𝗿 𝗕𝗶𝗼𝗽𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹𝘀 In biopharmaceutical manufacturing, 𝗽𝗿𝗼𝗰𝗲𝘀𝘀-𝗿𝗲𝗹𝗮𝘁𝗲𝗱 𝗶𝗺𝗽𝘂𝗿𝗶𝘁𝗶𝗲𝘀 can emerge at various stages including upstream processing like cell culture growth and harvest, downstream processing like purification, or the use of single-use technologies These impurities pose 𝘀𝗶𝗴𝗻𝗶𝗳𝗶𝗰𝗮𝗻𝘁 𝗿𝗶𝘀𝗸𝘀 to product quality and safety. The effective identification and removal of residual impurities are crucial for process validation, compliance, and maintaining the integrity of biologics. 𝗞𝗲𝘆 𝗜𝗺𝗽𝘂𝗿𝗶𝘁𝗶𝗲𝘀 𝘁𝗼 𝗠𝗼𝗻𝗶𝘁𝗼𝗿: • Cell-derived impurities  • Buffer components  • Antibiotics  • Surfactants  • Antifoaming agents  • Process-enhancing agents  • Catalysts  • Compounds leaching from contact materials Detecting these impurities is particularly challenging due to their low concentrations in complex matrices. At 𝗘𝘂𝗿𝗼𝗳𝗶𝗻𝘀 𝗕𝗶𝗼𝗣𝗵𝗮𝗿𝗺𝗮 𝗣𝗿𝗼𝗱𝘂𝗰𝘁 𝗧𝗲𝘀𝘁𝗶𝗻𝗴, we leverage state-of-the-art instrumentation to identify and quantify a wide range of impurities with precision and reliability under GMP. By combining innovative technology with deep expertise, we ensure that your biopharmaceutical products are 𝗳𝗿𝗲𝗲 𝗼𝗳 𝗵𝗮𝗿𝗺𝗳𝘂𝗹 𝗿𝗲𝘀𝗶𝗱𝘂𝗮𝗹𝘀. Contact our experts and discuss the impurities to be detected. 📩 BioPharma.Switzerland@bpt.eurofinseu.com #ResidualImpurity #Impurity #QualityControl #BioPharma #Biologics #Sterility #Bioprocess

𝗨𝗻𝗹𝗼𝗰𝗸𝗶𝗻𝗴 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝘄𝗶𝘁𝗵 𝗣𝗿𝗼𝘁𝗲𝗶𝗻 𝗖𝗵𝗮𝗿𝗮𝗰𝘁𝗲𝗿𝗶𝘇𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗔𝗻𝗮𝗹𝘆𝘀𝗶𝘀 Eurofins BPT 𝗽𝗿𝗼𝘁𝗲𝗶𝗻 𝗮𝗻𝗮𝗹𝘆𝘁𝗶𝗰𝘀 are essential for understanding the molecular composition, structure, and function of biologic drugs. These insights ensure targeted therapeutic outcomes while maintaining consistent quality across all batches in alignment with ICH Q6B guidelines. 𝗢𝘂𝗿 𝗰𝗼𝗺𝗽𝗿𝗲𝗵𝗲𝗻𝘀𝗶𝘃𝗲 𝗽𝗼𝗿𝘁𝗳𝗼𝗹𝗶𝗼 𝗼𝗳 𝗮𝗻𝗮𝗹𝘆𝘁𝗶𝗰𝗮𝗹 𝘁𝗲𝗰𝗵𝗻𝗶𝗾𝘂𝗲𝘀 𝗶𝗻𝗰𝗹𝘂𝗱𝗲𝘀: • 𝗖𝗼𝗺𝗽𝗲𝗻𝗱𝗶𝗮𝗹 𝗧𝗲𝘀𝘁𝘀: Ensuring compliance with pharmacopeial standards through assessments of e.g. appearance, clarity, color, pH, osmolality, and particulates.  • 𝗦𝗶𝘇𝗲 𝗮𝗻𝗱 𝗖𝗵𝗮𝗿𝗴𝗲 𝗩𝗮𝗿𝗶𝗮𝗻𝘁𝘀: Analyzing heterogeneity and stability using techniques like size exclusion, CE-SDS, SDS-PAGE, and IEX.  • 𝗚𝗹𝘆𝗰𝗼𝘀𝘆𝗹𝗮𝘁𝗶𝗼𝗻 𝗔𝗻𝗮𝗹𝘆𝘀𝗶𝘀: Profiling N-linked glycans to evaluate critical post-translational modifications. • 𝗣𝗿𝗼𝗰𝗲𝘀𝘀-𝗥𝗲𝗹𝗮𝘁𝗲𝗱 𝗜𝗺𝗽𝘂𝗿𝗶𝘁𝗶𝗲𝘀: Detecting residual impurities to ensure product safety and purity.  • 𝗖𝗼𝗻𝗰𝗲𝗻𝘁𝗿𝗮𝘁𝗶𝗼𝗻 𝗠𝗲𝗮𝘀𝘂𝗿𝗲𝗺𝗲𝗻𝘁𝘀: Providing accurate quantification of protein content.  • 𝗣𝗼𝘁𝗲𝗻𝗰𝘆 & 𝗕𝗶𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹 𝗔𝗰𝘁𝗶𝘃𝗶𝘁𝘆: Assessing the therapeutic functionality of your biologic. These in-depth analyses provide essential data to 𝘀𝘂𝗽𝗽𝗼𝗿𝘁 𝗸𝗲𝘆 𝗮𝗰𝘁𝗶𝘃𝗶𝘁𝗶𝗲𝘀:  • 𝗣𝗿𝗼𝗰𝗲𝘀𝘀 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁: Optimizing manufacturing processes to ensure scalability and efficiency.  • 𝗖𝗼𝗺𝗽𝗮𝗿𝗮𝗯𝗶𝗹𝗶𝘁𝘆 𝗦𝘁𝘂𝗱𝗶𝗲𝘀: Demonstrating product consistency during manufacturing changes.  • 𝗥𝗲𝗳𝗲𝗿𝗲𝗻𝗰𝗲 𝗠𝗮𝘁𝗲𝗿𝗶𝗮𝗹 (𝗥𝗲)𝗤𝘂𝗮𝗹𝗶𝗳𝗶𝗰𝗮𝘁𝗶𝗼𝗻𝘀: Preparing and requalifying critical testing standards.  • 𝗜𝗻𝘃𝗲𝘀𝘁𝗶𝗴𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗠𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴 𝗧𝗿𝗼𝘂𝗯𝗹𝗲𝘀𝗵𝗼𝗼𝘁𝗶𝗻𝗴: Resolving manufacturing issues efficiently.  • 𝗠𝗲𝘁𝗵𝗼𝗱 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁, 𝗩𝗮𝗹𝗶𝗱𝗮𝘁𝗶𝗼𝗻, 𝗮𝗻𝗱 𝗧𝗿𝗮𝗻𝘀𝗳𝗲𝗿: Designing and validating robust methods for reliable results.  Partner with us to achieve consistent quality and regulatory compliance through precise protein characterization. Contact us today to learn more! 📩 BioPharma.Switzerland@bpt.eurofinseu.com #ProteinCharacterization #Protein #BioPharma #Biologics #LargeMolecules #PoteinAnalytics

Our 𝗡𝗲𝘄 𝗪𝗲𝗯𝘀𝗶𝘁𝗲 is Live! Explore Our Services and Connect With Us! We’re thrilled to announce the launch of the new Eurofins BioPharma Product Testing Switzerland website! Designed to enhance your experience, our website provides seamless access to our local expertise and the comprehensive capabilities of our Eurofins BPT Network. 𝗘𝘅𝗽𝗹𝗼𝗿𝗲 𝗢𝘂𝗿 𝗢𝗻𝗲-𝗦𝘁𝗼𝗽-𝗦𝗵𝗼𝗽 𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻: • Environmental Monitoring & Utility Testing  • Microbiology  • Container Closure Integrity   • Extractables & Leachables   • Particle Testing   • Dissolution  • Chromatography   • Water Determination (Karl Fischer Titration)  • Nitrosamine Impurities   • Residual Impurities   • Bioassays and Potency Testing  • Protein Characterization   • Reference Material Qualification   • Stability Studies & Storage  • Raw Material  Do you require testing solutions for a method that isn’t listed?  Simply request 𝗰𝘂𝘀𝘁𝗼𝗺 𝘁𝗲𝘀𝘁𝗶𝗻𝗴 𝘀𝗲𝗿𝘃𝗶𝗰𝗲𝘀 via our contact form or directly at:    📩 BioPharma.Switzerland@bpt.eurofinseu.com Whether you’re looking for advanced testing methods, collaboration opportunities, or staying updated on our latest services and technical capabilities, our website is your go-to platform for detailed insights and information. 𝗩𝗶𝘀𝗶𝘁 𝗻𝗼𝘄 🌐: https://lnkd.in/ec-cYE-r #Eurofins #BioPharma #NewWebsite #Pharma #PharmaceuticalServices #Innovation 

𝗕𝗶𝗼𝗮𝘀𝘀𝗮𝘆𝘀: 𝗧𝗵𝗲 𝗞𝗲𝘆 𝘁𝗼 𝗕𝗶𝗼𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹 𝗣𝗼𝘁𝗲𝗻𝗰𝘆 𝗮𝗻𝗱 𝗤𝘂𝗮𝗹𝗶𝘁𝘆 𝗖𝗼𝗻𝘁𝗿𝗼𝗹 Bioassays are vital for determining the 𝗯𝗶𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹 𝗮𝗰𝘁𝗶𝘃𝗶𝘁𝘆 𝗮𝗻𝗱 𝗽𝗼𝘁𝗲𝗻𝗰𝘆 of biopharmaceuticals, ensuring they perform as intended. Guided by ICH Q6B, potency assays play a central role for quality control across a diverse range of biologics. 𝗢𝘂𝗿 𝗣𝗼𝘁𝗲𝗻𝗰𝘆 𝗔𝘀𝘀𝗮𝘆 𝗘𝘅𝗽𝗲𝗿𝘁𝗶𝘀𝗲 𝗖𝗼𝘃𝗲𝗿𝘀:  • Therapeutic Monoclonal and Bispecific Antibodies   • Antibody Drug Conjugates (ADC)   • Proteins and Peptides   • Cytokines (e.g., interferons)  • mRNA and DNA  • Oligonucleotides  • Vaccines   • Cell and Gene Therapies (ATMPs)   • Therapeutic Enzymes 𝗢𝘂𝗿 𝗖𝘂𝘀𝘁𝗼𝗺𝗶𝘇𝗲𝗱 𝗦𝗲𝗿𝘃𝗶𝗰𝗲 𝗣𝗼𝗿𝘁𝗳𝗼𝗹𝗶𝗼 𝗜𝗻𝗰𝗹𝘂𝗱𝗲𝘀:  • Potency Method Development and Optimization • Method Qualification/Validation/Transfer  • GMP Batch Release and Stability Testing  • Qualification of Critical Reagents  • Generation and Qualification of Master and Working Cell Banks for Potency Assays Recognizing the complexity of bioassays, we leverage innovative solutions, including semi-automated pipetting systems, Kanban, and 6S techniques, to ensure consistency and efficiency.  Additionally, our expertise in Surface Plasmon Resonance (SPR) and Bio-Layer Interferometry (BLI) offers precise insights for product characterization. Contact us to discuss the parameters and requirements of your biologics. 📩 BioPharma.Switzerland@bpt.eurofinseu.com   #BioAssay #PotencyAssay #PotencyTesting #Biologics #GMP #mRNA #ATMP #DNA 

𝗣𝗲𝗿𝗳𝗲𝗰𝘁𝗶𝗻𝗴 𝗗𝗶𝘀𝘀𝗼𝗹𝘂𝘁𝗶𝗼𝗻: 𝗧𝗵𝗲 𝗖𝗿𝗶𝘁𝗶𝗰𝗮𝗹 𝗥𝗼𝗹𝗲 𝗼𝗳 𝗗𝗼𝘀𝗮𝗴𝗲 𝗙𝗼𝗿𝗺𝘀   Selecting the appropriate 𝗗𝗼𝘀𝗮𝗴𝗲 𝗙𝗼𝗿𝗺 is crucial to achieving optimal therapeutic results. Each form is designed to address specific use cases and patient needs. At Eurofins PHAST Development in Konstanz, our 𝗗𝗶𝘀𝘀𝗼𝗹𝘂𝘁𝗶𝗼𝗻 𝗧𝗲𝘀𝘁𝗶𝗻𝗴 𝗦𝗲𝗿𝘃𝗶𝗰𝗲𝘀 cover various dosage forms, helping you identify the most effective solution tailored to your requirements. • 𝗜𝗺𝗺𝗲𝗱𝗶𝗮𝘁𝗲 𝗥𝗲𝗹𝗲𝗮𝘀𝗲 𝗗𝗼𝘀𝗮𝗴𝗲 𝗙𝗼𝗿𝗺 • 𝗛𝗮𝗿𝗱 𝗖𝗮𝗽𝘀𝘂𝗹𝗲  • 𝗦𝗼𝗳𝘁 𝗚𝗲𝗹𝗮𝘁𝗶𝗻 𝗖𝗮𝗽𝘀𝘂𝗹𝗲  • 𝗦𝘂𝘀𝘁𝗮𝗶𝗻𝗲𝗱 𝗥𝗲𝗹𝗲𝗮𝘀𝗲 𝗗𝗼𝘀𝗮𝗴𝗲 𝗙𝗼𝗿𝗺   • 𝗦𝗽𝗲𝗰𝗶𝗳𝗶𝗰 𝗗𝗼𝘀𝗮𝗴𝗲 𝗙𝗼𝗿𝗺: We can develop and test unique dosage forms, depending on your requirements and the intended use.   Understanding the diverse dosage types is crucial to improve overall treatment outcomes.   Let our experts guide you in selecting the right solution for your specific needs.   📩 Pharma.Konstanz@bpt.eurofinseu.com  And  📩 BioPharma.Switzerland@bpt.eurofinseu.com #Dissolution #DissolutionTesting #Capsule #QualityControl #GMP #Pharma #BioPharma #DosageForm